CAR-TCR Europe Summit
Novotel London West, Hammersmith, London, W6 8DR
February 24-27, 2020
What is the CAR-TCR Summit Europe?
Returning for the third year due to popular demand, the CAR-TCR Summit Europe is the definitive platform for the European community to tackle the technical bottlenecks limiting the translation, scale and delivery of CAR and TCR therapies to patients in need.
Providing you with the most comprehensive program to grace this side of the pond, across 4 days this summit will drill deeper into the innovations used to break the glass ceiling in manufacturing, safety management and patient accessibility.
Who is the CAR-TCR Summit for?
This meeting is exclusively curated for CAR and TCR drug developers actively working to engineer a cancer free world.
Bringing together the top minds from large pharma, biotech, academia and regulatory boards, join your community to network, share ideas and hear lessons learned to advance your own pipeline towards clinical and commercial success.
Overcome regulatory challenges to harmonize the EMA regulatory process with clinical experience from Medigene and Celgene, whilst learning from gamechangers from across the globe like Gracell and Immatics Biotherapeutics to disrupt current manufacturing norms to improve patient access.
Why is it paramount that your team attends?
Join forces with the CAR-TCR community to drive innovation. Through collaboration and frank, open conversations, as a field you can advance construct design to drive efficacy in solid tumours whilst characterizing the optimal product to improve persistence and durability.
Whether you are managing clinical trials or responsible for devising pricing models, this meeting can support your whole team to develop the tools needed to deliver on the promise of personalized CAR and TCR therapies.
Click here to download the full event guide. Next earlybird ends the 24th of January.
